MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer
Model using routine clinical data may predict pancreatic cancer risk
14 February 2022Illicit amphetamine (‘speed’) use linked to 5-fold heightened risk of psychosis
14 February 2022MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer
An interim analysis of an ongoing Phase III study from UCLA Jonsson Comprehensive Cancer Center indicates that using magnetic resonance imaging (MRI) to guide precisely-focused high-dose radiation treatment for prostate cancer reduced side effects associated with the treatment. The findings are being presented at the 2022 ASCO Genitourinary (GU) Cancers Symposium in San Francisco, California.
